In-licensing: Drug delivery & Immune related disorders

Latest: Watch here for details of new products and services.

Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Comparison
Forums: Visit our forums
Jobs: Visit our job site
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire New!
Contact us: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..3 of 3 - per page
Order by

Seeking late stage or currently marketed assets. More

Novel, late stage therapeutics are sought for marketing through a Europe wide specialist sales force. More

Palau Pharma is seeking an inflammation/autoimmune disorder commercialized drug with novel DDT, combination product More

Displaying 1..3 of 3 - per page
Order by

Industry sector: Intravesical; Nasal; Nasal topical; Ophthalmic; Oral liquid; Oral solid; Otic; Parenteral; Pulmonary; Rectal; Systemic; Topical; Vaginal
Therapeutic target: Adoptive immunotherapy; Amyloidosis; Autoimmune disease (non-specific); Chronic fatigue syndrome; Chronic granulomatous disease; Chronic immunosuppression; Gout; Graft versus host disease; HIV/AIDS; Immune disorder (non-specific); Immune thrombocytopenic purpura; Immunomodulation; Immunostimulation; Immunosuppression; Lupus erythematosis; Myalgic encephalomyelitis; Myasthenia gravis; Neoplastic disease; Organ transplant rejection; Rheumatoid arthritis; Servere combined immunodeficency; Sjogren's syndrome; Systemic sclerosis; Transplant rejection; Xenotransplantation
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Industry news: Pharmalicensing provides comprehensive industry coverage.